New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
March 27, 2015
14:04 EDTREGNRegeneron price target raised to $500 from $450 at Argus
Subscribe for More Information
10:03 EDTEQIXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:07 EDTEQIXEquinix initiated with a Neutral at Goldman
Subscribe for More Information
March 25, 2015
11:14 EDTCTRXCatamaran management to meet with Jefferies
Subscribe for More Information
11:03 EDTREGNRegeneron confirms FDA approval of EYLEA
Subscribe for More Information
10:35 EDTREGNFDA approves expanded indication for Eylea
Subscribe for More Information
March 24, 2015
14:56 EDTADIAnalog Devices management to meet with SunTrust
Subscribe for More Information
March 23, 2015
10:01 EDTCTRXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Allied World (AWH) initiated with a Market Perform at Keefe Bruyette... Capnia (CAPN) initiated with a Buy at Maxim... Catamaran (CTRX) initiated with a Buy at Mizuho... CyberArk (CYBR) initiated with a Buy at BofA/Merrill... Inotek Pharmaceuticals (ITEK) initiated with a Buy at Canaccord... Kinder Morgan (KMI) initiated with a Buy at Argus... MGM China (MCHVF) initiated with a Market Perform at Bernstein... Maxim Integrated (MXIM) initiated with a Buy at Summit Research... Melco Crown (MPEL) initiated with an Outperform at Bernstein... Microsemi (MSCC) initiated with an Outperform at BMO Capital... Sands China (SCHYY) initiated with an Outperform at Bernstein... Tetraphase (TTPH) initiated with a Buy at Nomura... Vista Outdoor (VSTO) initiated with a Sector Weight at KeyBanc... Wynn Macau (WYNMF) initiated with a Market Perform at Bernstein.
07:17 EDTREGNAmerican Academy of Dermatology to hold annual meeting
73rd Annual Meeting of AAD is being held in San Francisco on March 20-24.
06:18 EDTCTRXCatamaran initiated with a Buy at Mizuho
Subscribe for More Information
March 22, 2015
17:01 EDTWDCWestern Digital, PACCAR, two others look discounted, Barron's says
Subscribe for More Information
March 20, 2015
10:00 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:05 EDTREGNRegeneron initiated with a Buy at Chardan
Subscribe for More Information
March 19, 2015
10:02 EDTDISCAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:29 EDTDISCADiscovery initiated with a Buy at Rosenblatt
Target $38.
March 18, 2015
12:09 EDTDISCASony announces launch of PlayStation Vue in New York, Chicago, Philadelphia
Subscribe for More Information
06:31 EDTDISCADiscovery, Viacom in talks to be on Apple TV service, WSJ reports
Subscribe for More Information
05:15 EDTEQIXEquinix selects Singapore as strategic location for Asia-Pacific data center
Equinix announced the grand opening of its third International Business Exchange, or IBX, data center, known as SG3, in Singapore. The company's flagship data center is the largest in Asia-Pacific and demonstrates Equinix's ongoing commitment to the growing market demand for premium data center services from financial and cloud companies in the region. Equinix additionally announced that Orange Carriers Singapore, a 100 percent subsidiary of Orange Group, global communications solutions provider, and Datapipe, a global leader in managed hybrid IT solutions for the enterprise, have chosen to deploy in SG3 as part of their global expansion.
March 17, 2015
08:04 EDTWDCWestern Digital decline overdone, says RBC Capital
Subscribe for More Information
March 16, 2015
08:23 EDTREGNPCSK9 data continues to impress, says Leerink
Subscribe for More Information
07:28 EDTWDCWestern Digital, Seagate estimates lowered on PC weakness at Jefferies
Subscribe for More Information
07:16 EDTREGNRegeneron Sanofi dupilumab drug can generate $6B+ in revenue, says Bernstein
Bernstein believes that dupilumab, a drug made by Regeneron and Sanofi, has shown strong efficacy in patients with severe atopic dermatitis. The firm notes that the drug is currently in pivotal trials involving patients with severe levels of other common diseases. The firm thinks the drug can generate $1.5B of revenue by 2018 and $3.8B by 2020. Bernstein keeps a $500 price target and Outperform rating on Regeneron.
06:40 EDTREGNPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
06:05 EDTVRSKGen Re selects AIR Worldwide's Touchstone platform
Subscribe for More Information
March 15, 2015
19:33 EDTEQIXWalgreens Boots Alliance to replace Equinix in NASDAQ-100 Index as of 3/23
Subscribe for More Information
13:04 EDTREGNSanofi, Regeneron announce publication of results of ODYSSEY long term trial
Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) today announced that 18-month results of a Phase 3 trial of Praluent, alirocumab, an investigational therapy, involving 2,341 high risk patients with hypercholesterolemia were published online in The New England Journal of Medicine. In the ODYSSEY LONG TERM trial, Praluent 150 mg every two weeks reduced low-density lipoprotein cholesterol by an additional 62% at week 24 when compared to placebo, the primary efficacy endpoint of the study, with consistent LDL-C lowering maintained over 78 weeks."These results demonstrated the durable efficacy for Praluent when added to maximally-tolerated statin therapy and further reinforce its generally consistent safety profile," said Jennifer Robinson, M.D., M.P.H., Director of the Prevention Intervention Center, Professor, Departments of Epidemiology & Medicine, College of Public Health at the University of Iowa. "Additionally, the post hoc analysis of major cardiovascular events represents an important finding for Praluent -- we look forward to results from the ongoing ODYSSEY OUTCOMES trial, which is prospectively evaluating the potential of Praluent to reduce cardiovascular events."
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use